|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-11-20
|
|
pubmed:abstractText |
To compare therapeutic outcome and perform a cost-benefit analysis of inpatients with community-acquired pneumonia (CAP) treated with a shortened course of i.v. antibiotic therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
965-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8874253-Adult,
pubmed-meshheading:8874253-Aged,
pubmed-meshheading:8874253-Cefuroxime,
pubmed-meshheading:8874253-Cephalosporins,
pubmed-meshheading:8874253-Community-Acquired Infections,
pubmed-meshheading:8874253-Cost-Benefit Analysis,
pubmed-meshheading:8874253-Female,
pubmed-meshheading:8874253-Humans,
pubmed-meshheading:8874253-Length of Stay,
pubmed-meshheading:8874253-Male,
pubmed-meshheading:8874253-Middle Aged,
pubmed-meshheading:8874253-Pneumonia,
pubmed-meshheading:8874253-Prospective Studies,
pubmed-meshheading:8874253-Time Factors
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy.
|
|
pubmed:affiliation |
Department of Pulmonary and Critical Care Medicine, Bronx (NY) Veterans Affairs Medical Center 10468, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
